Bisphenol A and its analogs: Do their metabolites have endocrine activity?

Environmental Toxicology and Pharmacology

Volumn 47, Issue , 2016, Pages 182-199

  Gramec Skledar, Darja ^a   Peterlin Mašič, Lucija ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Bisphenol A; BPA analogs; Endocrine toxicity; Glucuronidation; Hormone disruptors; Oxidative metabolism

Indexed keywords

1,1,1,3,3,3 HEXAFLUORO 2,2 BIS(4 HYDROXYPHENYL)PROPANE; 2,2 BIS(4 HYDROXYPHENYL)BUTAN; 3,3' DIMETHYLBISPHENOL A; 4,4' ISOPROPYLIDENEDIPHENOL; BIS(4 HYDROXYPHENYL)METHANE; BIS(4 HYDROXYPHENYL)SULFONE; BISPHENOL A GLUCURONIDE; BISPHENOL A SULFATE; ENDOCRINE DISRUPTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCURONIDE; PHENOL DERIVATIVE; TETRABROMOBISPHENOL A; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; BIS(4-HYDROXYPHENYL)SULFONE; BISPHENOL B; BISPHENOL F; POLYBROMINATED BIPHENYL; SULFONE;

BIOLOGICAL MONITORING; BIOTRANSFORMATION; ECOTOXICITY; ENDOCRINE FUNCTION; ENVIRONMENTAL EXPOSURE; GLUCURONIDATION; HUMAN; METABOLISM; METABOLITE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; ANIMAL; CHEMISTRY;

ANIMALS; BENZHYDRYL COMPOUNDS; ENDOCRINE DISRUPTORS; HUMANS; PHENOLS; POLYBROMINATED BIPHENYLS; SULFONES;

EID: 84992476795     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2016.09.014     Document Type: Review

References (119)

1. Ćwiek-Ludwicka, K., Bisphenol A (BPA) in food contact materials—new scientific opinion from EFSA regarding public health risk. Rocz. Panstw. Zakl. Hig. 66 (2015), 299–307.
2. Alonso-Magdalena, P., Ropero, A.B., Soriano, S., García-Arévalo, M., Ripoll, C., Fuentes, E., Quesada, I., Nadal, Á., Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways. Mol. Cell. Endocrinol. 355 (2012), 201–207.
3. Atkinson, A., Roy, D., In vitro conversion of environmental estrogenic chemical bisphenol A to DNA binding metabolite(s). Biochem. Biophys. Res. Commun. 210 (1995), 424–433.
4. Atkinson, A., Roy, D., In vivo DNA adduct formation by bisphenol A. Environ. Mol. Mutagen. 26 (1995), 60–66.
5. Attia, S.M., Deleterious effects of reactive metabolites. Oxid. Med. Cell. Longevity 3 (2010), 238–253.
6. Audebert, M., Dolo, L., Perdu, E., Cravedi, J.P., Zalko, D., Use of the (H2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines. Arch. Toxicol. 85 (2011), 1463–1473.
7. Azzouz, A., Rascón, A.J., Ballesteros, E., Simultaneous determination of parabens, alkylphenols, phenylphenols, bisphenol A and triclosan in human urine, blood and breast milk by continuous solid-phase extraction and gas chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 119 (2015), 16–26.
8. Baker, M.E., Chandsawangbhuwana, C., 3D Models of MBP, a Biologically Active Metabolite of bisphenol A, in human estrogen receptor alpha and estrogen receptor beta. PLoS One, 7, 2012, e46078.
9. Boucher, J.G., Boudreau, A., Ahmed, S., Atlas, E., In-vitro effects of bisphenol A beta-D-glucuronide (BPA-G) on adipogenesis in human and murine preadipocytes. Environ. Health Persp. 123 (2015), 1287–1293.
10. Bursztyka, J., Perdu, E., Pettersson, K., Pongratz, I., Fernandez-Cabrera, M., Olea, N., Debrauwer, L., Zalko, D., Cravedi, J.P., Biotransformation of genistein and bisphenol A in cell lines used for screening endocrine disruptors. Tox. in Vitro. 22 (2008), 1595–1604.
11. Cabaton, N., Chagnon, M.C., Lhuguenot, J.C., Cravedi, J.P., Zalko, D., Disposition and metabolic profiling of bisphenol F in pregnant and nonpregnant rats. J. Agric. Food Chem. 54 (2006), 10307–10314.
12. Cabaton, N., Zalko, D., Rathahao, E., Canlet, C., Delous, G., Chagnon, M.C., Cravedi, J.P., Perdu, E., Biotransformation of bisphenol F by human and rat liver subcellular fractions. Toxicol. In Vitro 22 (2008), 1697–1704.
13. Cabaton, N., Dumont, C., Severin, I., Perdu, E., Zalko, D., Cherkaoui-Malki, M., Chagnon, M.C., Genotoxic and endocrine activities of bis(hydroxyphenyl)methane (bisphenol F) and its derivatives in the HepG2 cell line. Toxicology 255 (2009), 15–24.
14. Calafat, A.M., Ye, X., Wong, L.Y., Reidy, J.A., Needham, L.L., Exposure of the U: S. population to bisphenol A and 4-tertiary-octylphenol: 2003–2004. Environ. Health Perspect. 116 (2008), 39–44.
15. Chen, M.Y., Ike, M., Fujita, M., Acute toxicity, mutagenicity, and estrogenicity of bisphenol-A and other bisphenols. Environ. Toxicol. 17 (2002), 80–86.
16. Corbel, T., Gayrard, V., Puel, S., Lacroix, M.Z., Berrebi, A., Gil, S., Viguié, C., Toutain, P.L., Picard-Hagen, N., Bidirectional placental transfer of bisphenol A and its main metabolite bisphenol A-glucuronide, in the isolated perfused human placenta. Reprod. Toxicol. 47 (2014), 51–58.
17. Covaci, A., Den Hond, E., Geens, T., Govarts, E., Koppen, G., Frederiksen, H., Knudsen, L.E., Mørck, T.A., Gutleb, A.C., Guignard, C., Cocco, E., Horvat, M., Heath, E., Kosjek, T., Mazej, D., Tratnik, J.S., Castaño, A., Esteban, M., Cutanda, F., Ramos, J.J., Berglund, M., Larsson, K., Jönsson, B.A., Biot, P., Casteleyn, L., Joas, R., Joas, A., Bloemen, L., Sepai, O., Exley, K., Schoeters, G., Angerer, J., Kolossa-Gehring, M., Fiddicke, U., Aerts, D., Koch, H.M., Urinary BPA measurements in children and mothers from six European member states: overall results and determinants of exposure. Environ. Res. 141 (2015), 77–85.
18. Cunha, S.C., Fernandes, J.O., Quantification of free and total bisphenol A and bisphenol B in human urine by dispersive liquid-liquid microextraction (DLLME) and heart-cutting multidimensional gas chromatography-mass spectrometry (MD-GC/MS). Talanta 83 (2010), 117–125.
19. Cunha, S.C., Almeida, C., Mendes, E., Fernandes, J.O., Simultaneous determination of bisphenol A and bisphenol B in beverages and powdered infant formula by dispersive liquid-liquid micro-extraction and heart-cutting multidimensional gas chromatography-mass spectrometry. Food Addit. Contam. A 28 (2011), 513–526.
20. Draganov, D.I., Markham, D.A., Beyer, D., Waechter, J.M., Dimond, S.S., Budinsky, R.A., Shiotsuka, R.N., Snyder, S.A., Ehman, K.D., Hentges, S.G., Extensive metabolism and route-dependent pharmacokinetics of bisphenol A (BPA) in neonatal mice following oral or subcutaneous administration. Toxicology 333 (2015), 168–178.
21. Dumont, C., Perdu, E., de Sousa, G., Debrauwer, L., Rahmani, R., Cravedi, J.P., Chagnon, M.C., Bis(hydroxyphenyl)methane-bisphenol F-metabolism by the HepG2 human hepatoma cell line and cryopreserved human hepatocytes. Drug Chem. Toxicol. 34 (2011), 445–453.
22. Eladak, S., Grisin, T., Moison, D., Guerquin, M.J., N'Tumba-Byn, T., Pozzi-Gaudin, S., Benachi, A., Livera, G., Rouiller-Fabre, V., Habert, R., A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound. Fertil. Steril. 103 (2015), 11–21.
23. Elsby, R., Maggs, J.L., Ashby, J., Park, B.K., Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J. Pharmacol. Exp. Ther. 297 (2001), 103–113.
24. Fic, A., Zegura, B., Sollner Dolenc, M., Filipič, M., Peterlin Mašič, L., Mutagenicity and DNA damage of bisphenol A and its structural analogues in HepG2 cells. Arh. Hig. Rada Toksikol. 64 (2013), 189–200.
25. Fic, A., Zegura, B., Gramec, D., Mašič, L.P., Estrogenic and androgenic activities of TBBA and TBMEPH metabolites of novel brominated flame retardants, and selected bisphenols, using the XenoScreen XL YES/YAS assay. Chemosphere 112 (2014), 362–369.
26. Fini, J.B., Riu, A., Debrauwer, L., Hillenweck, A., Le Mevel, S., Chevolleau, S., Boulahtouf, A., Palmier, K., Balaguer, P., Cravedi, J.P., Demeneix, B.A., Zalko, D., Parallel biotransformation of tetrabromobisphenol A in Xenopus laevis and mammals: xenopus as a model for endocrine perturbation studies. Toxicol. Sci. 125 (2012), 359–367.
27. Fromme, H., Küchler, T., Otto, T., Pilz, K., Müller, J., Wenzel, A., Occurrence of phthalates and bisphenol A and F in the environment. Water Res. 36 (2002), 1429–1438.
28. Gramec Skledar, D., Troberg, J., Lavdas, J., Peterlin Mašič, L., Finel, M., Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10. Xenobiotica 45 (2015), 511–519.
29. Gramec, D., Peterlin Mašič, L., Sollner Dolenc, M., Bioactivation potential of thiophene-containing drugs. Chem. Res. Toxicol. 27 (2014), 1344–1358.
30. Grignard, E., Lapenna, S., Bremer, S., Weak estrogenic transcriptional activities of bisphenol A and bisphenol S. Toxicol. In Vitro 26 (2012), 727–731.
31. Héliès-Toussaint, C., Peyre, L., Costanzo, C., Chagnon, M.C., Rahmani, R., Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study. Toxicol. Appl. Pharmacol. 280 (2014), 224–235.
32. Hakk, H., Larsen, G., Bergman, A., Orn, U., Metabolism, excretion and distribution of the flame retardant tetrabromobisphenol-A in conventional and bile-duct cannulated rats. Xenobiotica 30 (2000), 881–890.
33. Hanioka, N., Naito, T., Narimatsu, S., Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Chemosphere 74 (2008), 33–36.
34. Hanioka, N., Oka, H., Nagaoka, K., Ikushiro, S., Narimatsu, S., Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation. Arch. Toxicol. 85 (2011), 1373–1381.
35. Hashimoto, Y., Moriguchi, Y., Oshima, H., Kawaguchi, M., Miyazaki, K., Nakamura, M., Measurement of estrogenic activity of chemicals for the development of new dental polymers. Toxicol. In Vitro 15 (2001), 421–425.
36. Huo, W., Xia, W., Wan, Y., Zhang, B., Zhou, A., Zhang, Y., Huang, K., Zhu, Y., Wu, C., Peng, Y., Jiang, M., Hu, J., Chang, H., Xu, B., Li, Y., Xu, S., Maternal urinary bisphenol A levels and infant low birth weight: A nested case-control study of the Health Baby Cohort in China. Environ. Int. 85 (2015), 96–103.
37. IPCS (International Programme on Chemical Safety), 1995. Environmental Health Criteria 172, Tetrabromobisphenol A and derivatives. World Health Organization Geneva, Switzerland . http://www.inchem.org/documents/ehc/ehc/ehc172.htm.
38. Inoue, H., Kemanai, S., Sano, C., Kato, S., Yokota, H., Iwano, H., Bisphenol A glucuroni de/sulfate diconjugate in perfused liver of rats. J. Vet. Med. Sci. 78 (2016), 733–737.
39. Ishibashi, H., Watanabe, N., Matsumura, N., Hirano, M., Nagao, Y., Shiratsuchi, H., Kohra, S., Yoshihara, S., Arizono, K., Toxicity to early life stages and an estrogenic effect of a bisphenol A metabolite, 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene on the medaka (Oryzias latipes). Life Sci. 77 (2005), 2643–2655.
40. Jaeg, J.P., Perdu, E., Dolo, L., Debrauwer, L., Cravedi, J.P., Zalko, D., Characterization of new bisphenol a metabolites produced by CD1 mice liver microsomes and S9 fractions. J. Agric. Food Chem. 52 (2004), 4935–4942.
41. Kang, J.S., Choi, J.S., Kim, W.K., Lee, Y.J., Park, J.W., Estrogenic potency of bisphenol S, polyethersulfone and their metabolites generated by the rat liver S9 fractions on a MVLN cell using a luciferase reporter gene assay. Reprod. Biol. Endocrinol., 12, 2014, 102.
42. Kitamura, S., Kato, T., Iida, M., Jinno, N., Suzuki, T., Ohta, S., Fujimoto, N., Hanada, H., Kashiwagi, K., Kashiwagi, A., Anti-thyroid hormonal activity of tetrabromobisphenol A, a flame retardant, and related compounds: Affinity to the mammalian thyroid hormone receptor, and effect on tadpole metamorphosis. Life Sci. 76 (2005), 1589–1601.
43. Kitamura, S., Suzuki, T., Sanoh, S., Kohta, R., Jinno, N., Sugihara, K., Yoshihara, S., Fujimoto, N., Watanabe, H., Ohta, S., Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds. Toxicol. Sci. 84 (2005), 249–259.
44. Knaak, J.B., Sullivan, L.J., Metabolism of bisphenol A in the rat. Toxicol. Appl. Pharmacol. 8 (1966), 175–184.
45. Knudsen, G.A., Sanders, J.M., Sadik, A.M., Birnbaum, L.S., Disposition and kinetics of Tetrabromobisphenol A in female Wistar Han rats. Toxicol. Rep. 1 (2014), 214–223.
46. Krishnan, A.V., Stathis, P., Permuth, S.F., Tokes, L., Feldman, D., Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132 (1993), 2279–2286.
47. Kurebayashi, H., Okudaira, K., Ohno, Y., Species difference of metabolic clearance of bisphenol A using cryopreserved hepatocytes from rats, monkeys and humans. Toxicol. Lett. 198 (2010), 210–215.
48. LaKind, J.S., Naiman, D.Q., Temporal trends in bisphenol A exposure in the United States from 2003–2012 and factors associated with BPA exposure: spot samples and urine dilution complicate data interpretation. Environ. Res. 142 (2015), 84–95.
49. Le Fol, V., Aït-Aïssa, S., Cabaton, N., Dolo, L., Grimaldi, M., Balaguer, P., Perdu, E., Debrauwer, L., Brion, F., Zalko, D., Cell-specific biotransformation of benzophenone-2 and bisphenol-s in zebrafish and human in vitro models used for toxicity and estrogenicity screening. Environ. Sci. Technol. 49 (2015), 3860–3868.
50. Lee, H.J., Chattopadhyay, S., Gong, E.Y., Ahn, R.S., Lee, K., Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor. Toxicol. Sci. 75 (2003), 40–46.
51. Li, M., Yang, Y., Yin, J., Zhang, J., Feng, Y., Shao, B., Biotransformation of bisphenol AF to its major glucuronide metabolite reduces estrogenic activity. PLoS One, 8, 2013, e83170.
52. Liao, C., Kannan, K., Concentrations and profiles of bisphenol A and other bisphenol analogues in foodstuffs from the United States and their implications for human exposure. J. Agric. Food Chem. 61 (2013), 4655–4662.
53. Liao, C., Liu, F., Guo, Y., Moon, H.B., Nakata, H., Wu, Q., Kannan, K., Occurrence of eight bisphenol analogues in indoor dust from the United States and several Asian countries: implications for human exposure. Environ. Sci. Technol. 46 (2012), 9138–9145.
54. Liao, C., Liu, F., Kannan, K., Bisphenol s, a new bisphenol analogue, in paper products and currency bills and its association with bisphenol a residues. Environ. Sci. Technol. 46 (2012), 6515–6522.
55. Liao, C., Liu, F., Moon, H.B., Yamashita, N., Yun, S., Kannan, K., Bisphenol analogues in sediments from industrialized areas in the United States, Japan, and Korea: spatial and temporal distributions. Environ. Sci. Technol. 46 (2012), 11558–11565.
56. Lin, J.H., Lu, A.Y., Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol. Rev. 49 (1997), 403–449.
57. Lotti, N., Colonna, M., Fiorini, M., Finelli, L., Berti, C., Poly(butylene terephthalate) modified with ethoxylated bisphenol S with increased glass transition temperature and improved thermal stability. Polymer 52 (2011), 901–911.
58. Markey, C.M., Michaelson, C.L., Veson, E.C., Sonnenschein, C., Soto, A.M., The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ. Health Perspect. 109 (2001), 55–60.
59. Matsushima, A., Liu, X., Okada, H., Shimohigashi, M., Shimohigashi, Y., Bisphenol AF is a full agonist for the estrogen receptor ERalpha but a highly specific antagonist for ERbeta. Environ. Health Perspect. 118 (2010), 1267–1272.
60. Matthews, J.B., Twomey, K., Zacharewski, T.R., In vitro and in vivo interactions of bisphenol A and its metabolite bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem. Res. Toxicol. 14 (2001), 149–157.
61. Mazur, C.S., Kenneke, J.F., Hess-Wilson, J.K., Lipscomb, J.C., Differences between human and rat intestinal and hepatic bisphenol A glucuronidation and the influence of alamethicin on in vitro kinetic measurements. Drug Metab. Dispos. 38 (2010), 2232–2238.
62. Michałowicz, J., Bisphenol A—sources, toxicity and biotransformation. Environ. Toxicol. Pharmacol. 37 (2014), 738–758.
63. Molina-Molina, J.M., Amaya, E., Grimaldi, M., Sáenz, J.M., Real, M., Fernández, M.F., Balaguer, P., Olea, N., In-vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. Toxicol. Appl. Pharmacol. 272 (2013), 127–136.
64. Nakagawa, Y., Suzuki, T., Metabolism of bisphenol A in isolated rat hepatocytes and oestrogenic activity of a hydroxylated metabolite in MCF-7 human breast cancer cells. Xenobiotica 31 (2001), 113–123.
65. Nakagawa, Y., Tayama, K., Metabolism and cytotoxicity of bisphenol A and other bisphenols in isolated rat hepatocytes. Arch. Toxicol. 74 (2000), 99–105.
66. Nakagawa, Y., Suzuki, T., Ishii, H., Ogata, A., Biotransformation and cytotoxicity of a brominated flame retardant tetrabromobisphenol A, and its analogues in rat hepatocytes. Xenobiotica 37 (2007), 693–708.
67. Nakamura, S., Tezuka, Y., Ushiyama, A., Kawashima, C., Kitagawara, Y., Takahashi, K., Ohta, S., Mashino, T., Ipso substitution of bisphenol A catalyzed by microsomal cytochrome P450 and enhancement of estrogenic activity. Toxicol. Lett. 203 (2011), 92–95.
68. National Toxicology Program, 2008. Chemical information profile for bisphenol AF [CAS No. 1478-61-1]. National Institute of Environ. Health Sci., National Institutes of Health. https://ntp.niehs.nih.gov/ntp/htdocs/chem_background/exsumpdf/bisphenolaf_093008_508.pdf.
69. Nishiyama, T., Ogura, K., Nakano, H., Kaku, T., Takahashi, E., Ohkubo, Y., Sekine, K., Hiratsuka, A., Kadota, S., Watabe, T., Sulfation of environmental estrogens by cytosolic human sulfotransferases. Drug Metab. Pharmacokinet. 17 (2002), 221–228.
70. Niwa, T., Fujimoto, M., Kishimoto, K., Yabusaki, Y., Ishibashi, F., Katagiri, M., Metabolism and interaction of bisphenol A in human hepatic cytochrome P450 and steroidogenic CYP17. Biol. Pharm. Bull. 24 (2001), 1064–1067.
71. Okuda, K., Takiguchi, M., Yoshihara, S., In vivo estrogenic potential of 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, an active metabolite of bisphenol A, in uterus of ovariectomized rat. Toxicol. Lett. 197 (2010), 7–11.
72. Okuda, K., Fukuuchi, T., Takiguchi, M., Yoshihara, S., Novel pathway of metabolic activation of bisphenol A-related compounds for estrogenic activity. Drug Metab. Dispos. 39 (2011), 1696–1703.
73. Perez, P., Pulgar, R., Olea-Serrano, F., Villalobos, M., Rivas, A., Metzler, M., Pedraza, V., Olea, N., The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. Environ. Health Perspect. 106 (1998), 167–174.
74. Pivnenko, K., Pedersen, G.A., Eriksson, E., Astrup, T.F., Bisphenol A and its structural analogues in household waste paper. Waste Manag. 44 (2015), 39–47.
75. Pottenger, L.H., Domoradzki, J.Y., Markham, D.A., Hansen, S.C., Cagen, S.Z., Waechter, J.M., The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol. Sci. 54 (2000), 3–18.
76. Pritchett, J.J., Kuester, R.K., Sipes, I.G., Metabolism of bisphenol a in primary cultured hepatocytes from mice, rats, and humans. Drug. Metab. Dispos. 30 (2002), 1180–1185.
77. Provencher, G., Bérubé, R., Dumas, P., Bienvenu, J.F., Gaudreau, E., Bélanger, P., Ayotte, P., Determination of bisphenol A, triclosan and their metabolites in human urine using isotope-dilution liquid chromatography–tandem mass spectrometry. J. Chromatogr. A. 1348 (2014), 97–104.
78. Richter, C.A., Birnbaum, L.S., Farabollini, F., Newbold, R.R., Rubin, B.S., Talsness, C.E., Vandenbergh, J.G., Walser-Kuntz, D.R., vom Saal, F.S., In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol. 24 (2007), 199–224.
79. Riu, A., Grimaldi, M., le Maire, A., Bey, G., Phillips, K., Boulahtouf, A., Perdu, E., Zalko, D., Bourguet, W., Balaguer, P., Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A. Environ. Health Perspect. 119 (2011), 1227–1232.
80. Rochester, J.R., Bisphenol A and human health: a review of the literature. Reprod. Toxicol. 42 (2013), 132–155.
81. Roelofs, M.J., van den Berg, M., Bovee, T.F., Piersma, A.H., van Duursen, M.B., Structural bisphenol analogues differentially target steroidogenesis in murine MA-10 Leydig cells as well as the glucocorticoid receptor. Toxicology 329 (2015), 10–20.
82. Rosenmai, A.K., Dybdahl, M., Pedersen, M., Alice van Vugt-Lussenburg, B.M., Wedebye, E.B., Taxvig, C., Vinggaard, A.M., Are structural analogues to bisphenol a safe alternatives?. Toxicol. Sci. 139 (2014), 35–47.
83. Rubin, B.S., Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J. Steroid. Biochem. Mol. Biol. 127 (2011), 27–34.
84. Rykowska, I., Wasiak, W., Properties, threats, and methods of analysis of bisphenol A and its derivatives. Acta. Chromatogr. 16 (2006), 7–27.
85. Schauer, U.M., Völkel, W., Dekant, W., Toxicokinetics of tetrabromobisphenol a in humans and rats after oral administration. Toxicol. Sci. 91 (2006), 49–58.
86. Schmidt, J., Peterlin Mašič, L., Organic synthetic environmental endocrine disruptors: structural classes and metabolic fate. Acta Chim. Slov. 59 (2012), 722–738.
87. Schmidt, J., Kotnik, P., Trontelj, J., Knez, Z., Masic, L.P., Bioactivation of bisphenol A and its analogs (BPF, BPAF, BPZ and DMBPA) in human liver microsomes. Toxicol. In Vitro 27 (2013), 1267–1276.
88. Shen, M., Cheng, J., Wu, R., Zhang, S., Mao, L., Gao, S., Metabolism of polybrominated diphenyl ethers and tetrabromobisphenol A by fish liver subcellular fractions in vitro. Aquat. Toxicol. 114–115 (2012), 73–79.
89. Shi, J., Yang, Y., Zhang, J., Feng, Y., Shao, B., Uptake, depuration and bioconcentration of bisphenol AF (BPAF) in whole-body and tissues of zebrafish (Danio rerio). Ecotoxicol. Environ. Saf. 132 (2016), 339–344.
90. Shimizu, M., Ohta, K., Matsumoto, Y., Fukuoka, M., Ohno, Y., Ozawa, S., Sulfation of bisphenol A abolished its estrogenicity based on proliferation and gene expression in human breast cancer MCF-7 cells. Toxicol. In Vitro 16 (2002), 549–556.
91. Skledar, D.G., Schmidt, J., Fic, A., Klopcic, I., Trontelj, J., Dolenc, M.S., Finel, M., Masic, L.P., Influence of metabolism on endocrine activities of bisphenol S. Chemosphere 157 (2016), 152–159.
92. Snyder, R.W., Maness, S.C., Gaido, K.W., Welsch, F., Sumner, S.C., Fennell, T.R., Metabolism and disposition of bisphenol A in female rats. Toxicol. Appl. Pharmacol. 168 (2000), 225–234.
93. Sohoni, P., Sumpter, J.P., Several environmental oestrogens are also anti-androgens. J. Endocrinol. 158 (1998), 327–339.
94. Street, C.M., Zhu, Z., Finel, M., Court, M.H., Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphisms. Xenobiotica 21 (2016), 1–10.
95. Suiko, M., Sakakibara, Y., Liu, M.C., Sulfation of environmental estrogen-like chemicals by human cytosolic sulfotransferases. Biochem. Biophys. Res. Commun. 267 (2000), 80–84.
96. Takayanagi, S., Tokunaga, T., Liu, X., Okada, H., Matsushima, A., Shimohigashi, Y., Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity. Toxicol. Lett. 167 (2006), 95–105.
97. Trdan Lušin, T., Roškar, R., Mrhar, A., Evaluation of bisphenol A glucuronidation according to UGT1A128 polymorphism by a new LC-MS/MS assay. Toxicology 292 (2012), 33–41.
98. Uhnáková, B., Ludwig, R., Pěknicová, J., Homolka, L., Lisá, L., Šulc, M., Petříčková, A., Elzeinová, F., Pelantová, H., Monti, D., Křen, V., Haltrich, D., Martínková, L., Biodegradation of tetrabromobisphenol A by oxidases in basidiomycetous fungi and estrogenic activity of the biotransformation products. Bioresour. Technol. 102 (2011), 9409–9415.
99. Völkel, W., Colnot, T., Csanády, G.A., Filser, J.G., Dekant, W., Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem. Res. Toxicol. 15 (2002), 1281–1287.
100. Vandenberg, L.N., Hauser, R., Marcus, M., Olea, N., Welshons, W.V., Human exposure to bisphenol A (BPA). Reprod. Toxicol. 24 (2007), 139–177.
101. Viñas, R., Watson, C.S., Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ. Health Perspect. 121 (2013), 352–358.
102. Waidyanatha, S., Mathews, J.M., Patel, P.R., Black, S.R., Snyder, R.W., Fennell, T.R., Disposition of bisphenol AF, a bisphenol A analogue, in hepatocytes in vitro and in male and female Harlan Sprague-Dawley rats and B6C3F1/N mice following oral and intravenous administration. Xenobiotica 45 (2015), 811–819.
103. Welshons, W.V., Nagel, S.C., vom Saal, F.S., Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147 (2006), 56–69.
104. Wetherill, Y.B., Akingbemi, B.T., Kanno, J., McLachlan, J.A., Nadal, A., Sonnenschein, C., Watson, C.S., Zoeller, R.T., Belcher, S.M., In vitro molecular mechanisms of bisphenol A action. Reprod. Toxicol. 24 (2007), 178–198.
105. Yamasaki, K., Sawaki, M., Takatsuki, M., Immature rat uterotrophic assay of bisphenol A. Environ. Health Perspect. 108 (2000), 1147–1150.
106. Yamasaki, K., Takeyoshi, M., Yakabe, Y., Sawaki, M., Imatanaka, N., Takatsuki, M., Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. Toxicology 170 (2002), 21–30.
107. Yang, Y., Guan, J., Yin, J., Shao, B., Li, H., Urinary levels of bisphenol analogues in residents living near a manufacturing plant in south China. Chemosphere 112 (2014), 481–486.
108. Yang, Y., Lu, L., Zhang, J., Wu, Y., Shao, B., Simultaneous determination of seven bisphenols in environmental water and solid samples by liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 1328 (2014), 26–34.
109. Ye, X., Kuklenyik, Z., Needham, L.L., Calafat, A.M., Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 383 (2005), 638–644.
110. Ye, X., Zhou, X., Needham, L.L., Calafat, A.M., In-vitro oxidation of bisphenol A: Is bisphenol A catechol a suitable biomarker for human exposure to bisphenol A?. Anal. Bioanal. Chem. 399 (2011), 1071–1079.
111. Ye, X., Wong, L.Y., Kramer, J., Zhou, X., Jia, T., Calafat, A.M., Urinary concentrations of bisphenol A and three other bisphenols in convenience samples of U.S. adults during 2000–2014. Environ. Sci. Technol. 49 (2015), 11834–11839.
112. Yokota, H., Iwano, H., Endo, M., Kobayashi, T., Inoue, H., Ikushiro, S., Yuasa, A., Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDP-glucuronosyltransferase, UGT2B1, in the rat liver. Biochem. J. 340 (1999), 405–409.
113. Yoshihara, S., Makishima, M., Suzuki, N., Ohta, S., Metabolic activation of bisphenol A by rat liver S9 fraction. Toxicol. Sci. 62 (2001), 221–227.
114. Yoshihara, S., Mizutare, T., Makishima, M., Suzuki, N., Fujimoto, N., Igarashi, K., Ohta, S., Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency. Toxicol. Sci. 78 (2004), 50–59.
115. Zalko, D., Soto, A.M., Dolo, L., Dorio, C., Rathahao, E., Debrauwer, L., Faure, R., Cravedi, J.P., Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ. Health Perspect. 111 (2003), 309–319.
116. Zalko, D., Prouillac, C., Riu, A., Perdu, E., Dolo, L., Jouanin, I., Canlet, C., Debrauwer, L., Cravedi, J.P., Biotransformation of the flame retardant tetrabromo-bisphenol A by human and rat sub-cellular liver fractions. Chemosphere 64 (2006), 318–327.
117. Zalko, D., Jacques, C., Duplan, H., Bruel, S., Perdu, E., Viable skin efficiently absorbs and metabolizes bisphenol A. Chemosphere 82 (2011), 424–430.
118. Zhou, X., Kramer, J.P., Calafat, A.M., Ye, X., Automated on-line column-switching high performance liquid chromatography isotope dilution tandem mass spectrometry method for the quantification of bisphenol A, bisphenol F, bisphenol S, and 11 other phenols in urine. J. Chromatogr. B 944 (2014), 152–156.
119. Zimmers, S.M., Browne, E.P., O'Keefe, P.W., Anderton, D.L., Kramer, L., Reckhow, D.A., Arcaro, K.F., Determination of free bisphenol A (BPA) concentrations in breast milk of U.S. women using a sensitive LC/MS/MS method. Chemosphere 104 (2014), 237–243.